Revenue - Nanobiotix SA (PAR:NANO) - Alpha Spread

Nanobiotix SA
PAR:NANO

Watchlist Manager
Nanobiotix SA Logo
Nanobiotix SA
PAR:NANO
Watchlist
Price: 4.646 EUR 4.31% Market Closed
Market Cap: 220.2m EUR
Have any thoughts about
Nanobiotix SA?
Write Note

Nanobiotix SA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nanobiotix SA
Revenue Peer Comparison

Comparables:
VLA
IPH
GNFT
ALERS
OSE

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Nanobiotix SA
PAR:NANO
Revenue
€30.1m
CAGR 3-Years
744%
CAGR 5-Years
204%
CAGR 10-Years
67%
Valneva SE
PAR:VLA
Revenue
€221.6m
CAGR 3-Years
26%
CAGR 5-Years
15%
CAGR 10-Years
20%
Innate Pharma SA
PAR:IPH
Revenue
€24.9m
CAGR 3-Years
-10%
CAGR 5-Years
-26%
CAGR 10-Years
11%
Genfit SA
NASDAQ:GNFT
Revenue
€38.2m
CAGR 3-Years
70%
CAGR 5-Years
38%
CAGR 10-Years
20%
Eurobio Scientific SA
PAR:ALERS
Revenue
€130m
CAGR 3-Years
-12%
CAGR 5-Years
21%
CAGR 10-Years
16%
OSE Immunotherapeutics SA
PAR:OSE
Revenue
€2.2m
CAGR 3-Years
-40%
CAGR 5-Years
-38%
CAGR 10-Years
N/A

Nanobiotix SA
Revenue Breakdown

Breakdown by Geography
Nanobiotix SA

Not Available

Breakdown by Segments
Nanobiotix SA

Total Revenue: 30.1m EUR
100%
Other Sales: 5k EUR
0%
Services: 5k EUR
0%

See Also

What is Nanobiotix SA's Revenue?
Revenue
30.1m EUR

Based on the financial report for Dec 31, 2023, Nanobiotix SA's Revenue amounts to 30.1m EUR.

What is Nanobiotix SA's Revenue growth rate?
Revenue CAGR 10Y
67%

The average annual Revenue growth rates for Nanobiotix SA have been 744% over the past three years , 204% over the past five years , and 67% over the past ten years .

Back to Top